Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got more...
Hi there, and happy Wednesday from STAT’s London bureau, with Andrew Joseph here tag-teaming today’s edition with Mr. Pharmalot. We’re in the midst of those confusing...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Today’s the deadline for the White...
Merck said Wednesday that it intends to buy Terns Pharmaceuticals, the developer of a promising leukemia treatment, for $6.7 billion. The deal values Terns at $53...
Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech called Loxo Oncology, and his boss,...
The war with Iran has focused the world’s attention on nuclear weapons and oil. Those risks are real. But there is a third category of danger...
It was 2023. ChatGPT had been released less than five months earlier. Justin Norden was sitting around a table with a dozen health care leaders at...
I recently spent a long afternoon hiding from the nurse in the emergency room of a prestigious hospital. My sister and I were there with my...
WASHINGTON — Robert Malone, an outspoken medical doctor and ally of health secretary Robert F. Kennedy Jr., is stepping away from a panel of federal vaccine...
Deepfake images can mislead viewers, upend elections, and instigate violence. They can also, researchers say, disrupt medical care. In a study published Tuesday in Radiology, an...